Bernstein Harold

President, R&D & CMOMaze Therapeutics, Inc. (MAZE) · full profile →Form 4 · filed Feb 4, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$690K
Net Open-Market Flow
-$690K
Transactions
6
5 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 2, 2026Option exercise(M)15K$10.42$156K15K
Feb 2, 2026Sell(S)600$44.21$27K14K
Feb 2, 2026Sell(S)8K$45.89$384K6K
Feb 2, 2026Sell(S)100$47.23$5K0
Feb 2, 2026Sell(S)6K$46.37$275K100

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 2, 2026Option exercise(M)15K$0297K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0002050172-26-000009) within minutes of acceptance. Every field above traces to the original document. Verify it directly: